Is LENZ Therapeutics, Inc. overvalued?

LENZ Therapeutics, Inc. (LENZ) — key valuation metrics and fundamentals.

No verdict

Price

$4.73

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$148.3M

Dividend yield

276.8%

Return on equity

-46.8%

Sector

Healthcare

Fair value compares LENZ's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.

Related stocks